Sex-Specific Efficacy and Safety in HF Trials: Inclusion Is Only the First Step

By sjmartinez • November 18, 2024

Khan S, Yancy CW, Fonarow GC. Sex-Specific Efficacy and Safety in HF Trials: Inclusion Is Only the First Step. JAMA Cardiol. 2024 Nov 17. doi: 10.1001/jamacardio.2024.4624. Epub ahead of print. PMID: 39550719.

Tags: Cardiology/Epi, Publications

Outcome of Patients Presenting With High-Risk Pulmonary Embolism Treated With Mechanical Thrombectomy: A Subgroup Analysis From the STRIKE-PE Study

Sharp ASP, Dohad SY, Weinberg I, Kurzyna M, Davis HC, Stepniewski J, Perkowski PE, Holden A, West FM, Keeling WB, Parikh SA, Moriarty JM. Outcome[...]

Glucagon-Like Peptide 1 Receptor Agonists are Associated With Reduced Risk of Hepatic Encephalopathy in Cirrhosis

Singh V, Wang M, Ebinger J, Velazquez A, Cheng S, Kwan AC, Trivedi HD. Glucagon-Like Peptide 1 Receptor Agonists are Associated With Reduced Risk of[...]

Temporal Trends and Future Projections of Pulmonary Embolism and Top Contributing Causes of death in the United States, 1968-2040: insights from the CDC WONDER database

Khan S, Abbas F, Hassan M, Hussain M, Ahmed M, Ahsan A, Qureshi S, Khalid N, Sajjad A, Baig M, Waqas SA, Fonarow GC, Greene[...]